Cargando…
NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats
Schizophrenia patients exhibit a decreased ability to detect change in their auditory environment as measured by auditory event-related potentials (ERP) such as mismatch negativity. This deficit has been linked to abnormal NMDA neurotransmission since, among other observations, non-selective channel...
Autores principales: | Sivarao, Digavalli V., Chen, Ping, Yang, Yili, Li, Yu-Wen, Pieschl, Rick, Ahlijanian, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122188/ https://www.ncbi.nlm.nih.gov/pubmed/25140157 http://dx.doi.org/10.3389/fpsyt.2014.00096 |
Ejemplares similares
-
The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver
por: Bromek, Ewa, et al.
Publicado: (2021) -
The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain
por: Haduch, Anna, et al.
Publicado: (2022) -
The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development
por: Keavy, Deborah, et al.
Publicado: (2016) -
Preparation 606
Publicado: (1910) -
Syphilis and "606."
Publicado: (1910)